Cargando…
Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
BACKGROUND: Verification of cerebrospinal fluid (CSF) biomarkers for multiple sclerosis and other neurological diseases is a major challenge due to a large number of candidates, limited sample material availability, disease and biological heterogeneity, and the lack of standardized assays. Furthermo...
Autores principales: | Guldbrandsen, Astrid, Lereim, Ragnhild Reehorst, Jacobsen, Mari, Garberg, Hilde, Kroksveen, Ann Cathrine, Barsnes, Harald, Berven, Frode S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499868/ https://www.ncbi.nlm.nih.gov/pubmed/32963504 http://dx.doi.org/10.1186/s12014-020-09296-5 |
Ejemplares similares
-
Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis
por: Oveland, Eystein, et al.
Publicado: (2021) -
In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
por: Guldbrandsen, Astrid, et al.
Publicado: (2014) -
Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients
por: Berle, Magnus, et al.
Publicado: (2013) -
Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome
por: Aasebø, Elise, et al.
Publicado: (2014) -
The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis
por: Lereim, Ragnhild Reehorst, et al.
Publicado: (2016)